ReviewCancer chemotherapy and pharmacology2022

Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells.

Rachel E Nicoletto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.